Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001.
| Image |  |
|---|---|
| Description | scientific article published in March 2015 |
| Author/s |
author: Mitsune Tanimoto Katsuyuki Hotta Katsuyuki Kiura Daijiro Harada Toshiyuki Kozuki Daizo Kishino Hiroshi Ueoka Keisuke Aoe Shoichi Kuyama Toshio Kubo Akihiro Bessho Akiko Hisamoto-Sato Kenichi Chikamori Shinobu Hosokawa Nagio Takigawa Naoyuki Nogami Eiki Ichihara |
| Publication date | March 1, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |